Perrigo Company (PRGO): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Perrigo Company ( PRGO) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.4%. By the end of trading, Perrigo Company rose $2.98 (2.4%) to $128.39 on heavy volume. Throughout the day, 1,947,737 shares of Perrigo Company exchanged hands as compared to its average daily volume of 927,900 shares. The stock ranged in a price between $124.71-$128.39 after having opened the day at $125.59 as compared to the previous trading day's close of $125.41. Other companies within the Health Care sector that increased today were: Stereotaxis ( STXS), up 74.8%, Aastrom Biosciences ( ASTM), up 35.6%, CEL-SCI Corporation ( CVM), up 19.2% and Skystar Bio-Pharmaceutical Company ( SKBI), up 17.5%.

Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API) worldwide. Perrigo Company has a market cap of $11.7 billion and is part of the drugs industry. Shares are up 20.4% year to date as of the close of trading on Thursday. Currently there are 11 analysts that rate Perrigo Company a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Perrigo Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Mast Therapeutics ( MSTX), down 38.4%, Organovo Holdings ( ONVO), down 14.0%, Aoxing Pharmaceutical Company ( AXN), down 12.0% and LipoScience ( LPDX), down 10.4% , were all laggards within the health care sector with Humana ( HUM) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Incoming Perrigo CEO Brings Strong Operations Experience

Incoming Perrigo CEO Brings Strong Operations Experience

These Are the Biggest Winners and Losers in Activist Investing This Year

These Are the Biggest Winners and Losers in Activist Investing This Year

McDonald's Takes Bite Out of Dow, but Nasdaq and S&P 500 at Records

McDonald's Takes Bite Out of Dow, but Nasdaq and S&P 500 at Records

Perrigo Stock Jumps as Starboard's Smith Says Generic Drugs a Strong Business

Perrigo Stock Jumps as Starboard's Smith Says Generic Drugs a Strong Business

Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain

Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain